Moriarty John B
Chief Legal Officer
Moriarty John B has filed 4 SEC Form 4 filings (5 transaction rows) across 3 companies, including KARD, RNAM, RNA, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jun 22, 2026.
On the most recent filing, Moriarty John B is listed as Chief Legal Officer at Avidity Biosciences, Inc. Inside the rolling window, Moriarty John B reported no open-market purchases and 1 open-market sale totaling $171K in RNA.
Companies traded
Other insiders at KARD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$171K
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Moriarty John B made?
Moriarty John B has filed 4 SEC Form 4 filings (5 transaction rows) across 3 companies, including KARD, RNAM, RNA since 2025.
Which companies does Moriarty John B trade?
Moriarty John B has filed SEC Form 4 disclosures for 3 companies, including KARD, RNAM, RNA.
When was Moriarty John B's most recent SEC Form 4 filing?
Moriarty John B's most recent SEC Form 4 filing on Tracefour is dated Jun 22, 2026.
What is Moriarty John B's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Moriarty John B is listed as Chief Legal Officer.
What is Moriarty John B's total buy and sell value in the current window?
Inside the rolling retention window, Moriarty John B bought $0 and sold $171K based on SEC Form 4 filings.
What was Moriarty John B's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,374 RNA shares on 2026-01-07, worth $171K, per SEC Form 4 filings.